X4 Pharmaceuticals to Present at the Stifel 2020 Virtual Healthcare Conference
BOSTON, Nov. 10, 2020 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of...
Day: November 10, 2020
ORYZON Receives Approval to Start PORTICO Phase IIb Trial with Vafidemstat in Borderline Personality Disorder
Clinical Trial Application approved by Spanish Drug Agency Builds on clinical data from two Phase IIa trials Primary objectives: reduction...
NeuBase Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17
PITTSBURGH, Nov. 10, 2020 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating...
Cue Biopharma to Host Business Update Call and Webcast
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class...
Healthwise Recognized for Plain Language Excellence with 2020 ClearMark Awards
Healthwise health education awarded top honors BOISE, Idaho, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Healthwise announced today that it captured...
Selecta Biosciences to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...
WellSpan Health Partners with VisitPay to Improve the Patient Financial Experience
200+ care locations to benefit from optimized and consolidated billing experience, setting a heightened standard for financial transparency BOISE, Idaho,...
Establishment Labs to Participate in Two Upcoming Investment Conferences
SANTA BARBARA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused...
Sun BioPharma, Inc. to Participate in the 11th Annual Craig-Hallum Alpha Select Conference
MINNEAPOLIS, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for...
AzurRx BioPharma Identifies Asymchem as Potential Partner of Choice for MS1819 Phase 3 Clinical Trial Drug Production
DELRAY BEACH, Fla., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing...
TCR² Therapeutics Announces Partnership with ElevateBio to Expand TC-210 Manufacturing Capacity
- ElevateBio BaseCamp to support anticipated TC-210 Phase 2 clinical trial demand CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) --...
Innovative Cellular Therapeutics to Participate in Upcoming Investor Conferences
ROCKVILLE, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive...
Aerpio Reports Third Quarter 2020 Financial Results and Provides Business Update
Enrollment completed in the 28-day Phase 2 razuprotafib glaucoma trial; topline data expected to be reported in December 2020 or...
Wave Life Sciences to Present at the 29th Annual Credit Suisse Healthcare Conference
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed...
STRATA Skin Sciences Reports Third Quarter 2020 Financial Results
HORSHAM, Pa., Nov. 10, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in...
Neoleukin Therapeutics Presents Preclinical Combination Data for NL-201 at Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting (SITC 2020)
- NL-201 enhances activity of checkpoint inhibitors and tumor-targeting antibodies and increases immune cell stimulation - SEATTLE, Nov. 10, 2020...
Applied Molecular Transport Announces Publication of Preclinical Data Demonstrating Potential of Novel Oral IL-10 Biologic Therapeutic (AMT-101) for Inflammatory Diseases in The Journal of Immunology
- AMT-101 (oral fusion protein of hIL-10 and AMT carrier) rapidly and efficiently transports through intestinal epithelia in healthy and...
AVITA Therapeutics, Inc.: Results of 2020 Annual Meeting of Shareholders
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 10, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a...
Genmab to Present at Jefferies Virtual London Healthcare Conference
Media ReleaseCopenhagen, Denmark, November 10, 2020Genmab A/S (Nasdaq: GMAB) announced today that its CEO, Jan van de Winkel, Ph.D. and...
Arch Raises Approximately $1.1 Million with Convertible Note Issuance
Financing with long-term shareholders provides flexibility during product roll-out FRAMINGHAM, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc....